500 mg
Trade Name
Medrolone
Lyophilisate for solution for injection
Request Type
New Registration
Drug Type
Generic(Multisource) Drug
Approval Date
SFDA Approved Use
Methylprednisolone is indicated to treat any condition in which rapid and intense corticosteroid effect is
required such as:
1. Dermatological disease
Severe erythema multiforme (Stevens-Johnson syndrome)
2. Allergic states
Bronchial asthma
Angioneurotic oedema
Anaphylaxis
3. Gastro-intestinal diseases
Ulcerative colitis
Crohn"s disease
4. Respiratory diseases
Aspiration of gastric contents
Fulminating or disseminated tuberculosis (with appropriate anti-tuberculous chemotherapy)
5. Neurological disorders
Cerebral oedema secondary to cerebral tumour Acute exacerbations of multiple sclerosis superimposed on a relapsing-remitting background
6. Miscellaneous
T.B. meningitis (with appropriate antituberculous chemotherapy)
required such as:
1. Dermatological disease
Severe erythema multiforme (Stevens-Johnson syndrome)
2. Allergic states
Bronchial asthma
Angioneurotic oedema
Anaphylaxis
3. Gastro-intestinal diseases
Ulcerative colitis
Crohn"s disease
4. Respiratory diseases
Aspiration of gastric contents
Fulminating or disseminated tuberculosis (with appropriate anti-tuberculous chemotherapy)
5. Neurological disorders
Cerebral oedema secondary to cerebral tumour Acute exacerbations of multiple sclerosis superimposed on a relapsing-remitting background
6. Miscellaneous
T.B. meningitis (with appropriate antituberculous chemotherapy)